Skip to main content

Table 1 Clinical and laboratory characteristics of the CLL patients evaluated using methylation and gene expression arrays

From: Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia

Characteristics of the patients

Sr. No

Sample ID

Methylation array

GE array

Rai stage

Age

Tumor Percentage

IGHV status

β2M(mg/L)

17p Deletion

IPI Score

1

S1

√

 

0

41

67.2

UM

6.56

Absent

4

2

S2

√

√

0

63

69

UM

4.06

Absent

4

3

S3

√

√

0

69

88.6

UM

8.42

Absent

5

4

S4

√

√

I

45

95.4

UM

4.6

Present

9

5

S5

√

√

I

60

93.5

UM

3.37

Absent

3

6

S6

√

√

II

50

66

UM

4.78

Absent

5

7

S7

√

 

II

59

97.2

M

3.54

Absent

3

8

S8

√

 

0

57

95.3

M

6.49

Absent

2

9

S9

√

 

II

65

92.8

M

4.58

Absent

3

10

S10

√

√

0

61

69.3

M

3.3

Absent

0

11

S11

√

√

II

65

97.2

M

4.48

Present

7

12

S12

√

√

II

67

98

UM

5.69

Absent

6

13

S13

√

√

II

48

92

UM

4.42

Absent

5

14

S14

√

 

I

58

95.62

UM

6.31

Absent

5

15

S15

 

√

I

46

79.4

UM

6.78

Absent

5

16

S16

 

√

II

59

73

UM

4.43

Absent

5

17

S17

 

√

I

40

90

UM

7.74

Absent

5

18

S18

 

√

I

67

79.3

UM

2.59

Absent

4

19

S19

 

√

I

51

80

M

5.44

Absent

3

20

S20

 

√

0

57

72.5

M

2.91

Absent

0

21

S21

 

√

II

65

68.6

M

7.1

Absent

2

22

S22

 

√

II

52

66

M

3.2

Absent

1

23

S23

 

√

I

60

92

M

6.56

Absent

3

24

S24

 

√

I

44

85.1

M

3.62

Absent

3

25

S25

 

√

II

68

93

M

6.47

Absent

4

26

S26

 

√

II

80

68.4

M

6.46

Absent

4

  1. Abbreviations used: GE Gene expression, UM Unmutated, M Mutated , β 2 M Beta 2 Microglobulin, IPI International Prognostic index